Propranolol for drug-resistant focal epilepsy
Treatments studied
Part of Brain & nervous system clinical trials.
This trial tests if adding propranolol (a beta-blocker usually used for high blood pressure) to your current epilepsy medicines can help control focal seizures that last a minute or longer and affect awareness. It's for people aged 18-60 whose seizures haven't been controlled by at least two other seizure medicines.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 60 years old.
- You have focal epilepsy (seizures that start in one part of the brain) that has not been controlled by at least two seizure medicines for 2 years.
- Your seizures last a minute or more and include a change in awareness or sensation.
- You have had at least 6 focal seizures in the last 3 months.
- You are not currently taking a beta-blocker (like propranolol or atenolol) and have not taken one in the last year.
- You do not have a history of asthma, certain heart conditions, or low blood pressure.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if the drug sirolimus can help people with focal seizures (starting in one part of the brain) that don't improve with at least two other medications. It aims to reduce seizure frequency in adults aged 18 to 60.
This trial tests XEN1101 compared with a placebo (inactive pill) in people with focal-onset seizures that haven’t been fully controlled despite trying at least two anti-seizure medicines. If you qualify, you may help researchers see whether the study drug reduces seizure frequency and improves control.
This trial looks at ways to diagnose and treat focal epilepsy that isn't controlled by medications. It includes patients with or without a visible brain lesion on imaging.
This trial tests a new medication, CB03-154, to see if it is safe and can reduce seizures in adults with focal epilepsy. You may be able to join if you have had focal epilepsy for at least 2 years and are on a stable dose of 1 to 3 anti-seizure medications.
This trial studies whether propranolol, a beta-blocker medicine, can help people with VHL who have non-urgent hemangioblastomas in the brain/spinal cord. It aims to see if the medication is safe and beneficial without needing immediate surgery.
This study tests a new medicine called BHV-7000 for adults whose focal seizures (starting in one part of the brain) are not controlled by current treatments. The goal is to see if it can reduce seizures safely.
Hear when a new Epilepsy, Drug Resistant trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.